Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

(2016) Jennifer S Temel et al.   LANCET ONCOLOGY

Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016

(2016) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Anorexia Assessment in Patients With Cancer: A Crucial Issue to Improve the Outcome

(2015) Alessio Molfino et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)

(2015) Thomas W. LeBlanc et al.   SUPPORTIVE CARE IN CANCER

Management of Anorexia-Cachexia in Late-Stage Lung Cancer Patients

(2012) Catherine Del Ferraro et al.   Journal of Hospice & Palliative Nursing

Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial

(2011) C. Baldwin et al.   JOURNAL OF HUMAN NUTRITION AND DIETETICS

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Weight change in later life and risk of death amongst the elderly: the European Prospective Investigation into Cancer and Nutrition-Elderly Network on Ageing and Health study

(2010) C. Bamia et al.   JOURNAL OF INTERNAL MEDICINE

Self-reported fatigue: one dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy—Fatigue (FACIT-F) questionnaire

(2010) David Cella et al.   SUPPORTIVE CARE IN CANCER

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008

(2009) Ali Montazeri   Health and Quality of Life Outcomes

Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report

(2009) Margaret Rothman et al.   VALUE IN HEALTH

The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer

(2008) M McKernan et al.   BRITISH JOURNAL OF CANCER

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY